$1.19
3.25% yesterday
Nasdaq, Oct 17, 09:43 pm CET
ISIN
US03837C1062
Symbol
APYX

Apyx Medical Corporation Stock price

$1.19
+0.11 10.19% 1M
-0.13 9.85% 6M
-1.43 54.58% YTD
-1.39 53.88% 1Y
-12.06 91.02% 3Y
-5.71 82.75% 5Y
-5.50 82.21% 10Y
Nasdaq, Closing price Thu, Oct 17 2024
-0.04 3.25%
ISIN
US03837C1062
Symbol
APYX
Sector

Key metrics

Market capitalization $41.23m
Enterprise Value $47.43m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 0.97
P/S ratio (TTM) P/S ratio 0.84
P/B ratio (TTM) P/B ratio 2.80
Revenue growth (TTM) Revenue growth 3.36%
Revenue (TTM) Revenue $49.03m
EBIT (operating result TTM) EBIT $-22.58m
Free Cash Flow (TTM) Free Cash Flow $-8.02m
Cash position $32.68m
EPS (TTM) EPS $-0.82
P/E forward negative
P/S forward 0.81
EV/Sales forward 0.93
Short interest 0.73%
Show more

Is Apyx Medical Corporation a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,907 stocks worldwide.

Apyx Medical Corporation Stock Analysis

Unlock Scores for Free

Analyst Opinions

5 Analysts have issued a Apyx Medical Corporation forecast:

2x Buy
40%
3x Hold
60%

Analyst Opinions

5 Analysts have issued a Apyx Medical Corporation forecast:

Buy
40%
Hold
60%

Financial data from Apyx Medical Corporation

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '24
+/-
%
49 49
3% 3%
100%
- Direct Costs 38 38
7% 7%
77%
11 11
6% 6%
23%
- Selling and Administrative Expenses 28 28
0% 0%
57%
- Research and Development Expense 5.35 5.35
15% 15%
11%
-22 -22
7% 7%
-45%
- Depreciation and Amortization 0.65 0.65
16% 16%
1%
EBIT (Operating Income) EBIT -23 -23
6% 6%
-46%
Net Profit -28 -28
74% 74%
-58%

In millions USD.

Don't miss a Thing! We will send you all news about Apyx Medical Corporation directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Apyx Medical Corporation Stock News

Neutral
PRNewsWire
2 months ago
Independent survey reveals Renuvion is #1 trusted body contouring technology* with plastic and cosmetic surgeons. CLEARWATER, Fla.
Neutral
Seeking Alpha
2 months ago
Apyx Medical Corporation (NASDAQ:APYX ) Q2 2024 Earnings Conference Call August 8, 2024 8:30 AM ET Company Participants Charles Goodwin - President, Chief Executive Officer & Director Matthew Hill - Chief Financial Officer Conference Call Participants Matt Hewitt - Craig-Hallum Capital Frank Takkinen - Lake Street Capitals George Sellers - Stephens Inc Operator Hello, and welcome, ladies and ge...
Neutral
Business Wire
2 months ago
CLEARWATER, Fla.--(BUSINESS WIRE)--Apyx Medical Corporation (NASDAQ:APYX) (“Apyx Medical”; the “Company”), the manufacturer of a proprietary helium plasma and radiofrequency platform technology marketed and sold as Renuvion®, today announced the publication of a peer-reviewed article in the journal, Plastic and Reconstructive Surgery—Global Open, featuring the results of study which compared th...
More Apyx Medical Corporation News

Company Profile

Apyx Medical Corp. operates as an energy-based medical technology company. The firm engages in developing, manufacturing, and marketing a range of electrosurgical products and technologies, as well as related medical products used the offices of doctors, surgery centers, and hospitals worldwide. It operates through the following segments: Advanced Energy and Original Equipment Manufacture (OME). The company was founded by Andrew Makrides in 1978 and is headquartered in Clearwater, FL.

Head office United States
CEO Charles Goodwin
Employees 252
Founded 1978
Website apyxmedical.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today